MRD-driven treatment paradigm for newly diagnosed transplant eligible multiple myeloma patients. Article uri icon

Overview

publication date

  • February 29, 2016

Research

keywords

  • Multiple Myeloma
  • Thalidomide

Identity

Scopus Document Identifier

  • 84959232451

Digital Object Identifier (DOI)

  • 10.1038/bmt.2016.24

PubMed ID

  • 26926231

Additional Document Info

volume

  • 51

issue

  • 7